Want to see TSE:NEWU.H full AI Analyst Report?
Top Page
Rating:―N/A
Price Target:―
Action:N/A
Date:―
No summary available
Positive Factors
High Client Engagement
High client engagement and positive health outcomes underscore the effectiveness of Newtopia's programs, strengthening client relationships and supporting retention, which are vital for sustained revenue growth and market differentiation.
Negative Factors
Negative Cash Flow
Negative cash flow trends suggest Newtopia is not generating sufficient cash from operations, increasing reliance on external funding. This could constrain liquidity and operational flexibility, impacting future growth and sustainability.
Read all positive and negative factors
Positive Factors
Negative Factors
High Client Engagement
High client engagement and positive health outcomes underscore the effectiveness of Newtopia's programs, strengthening client relationships and supporting retention, which are vital for sustained revenue growth and market differentiation.
Read all positive factors
Newtopia (NEWU.H) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$866.33K
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)-0.36
Revenue GrowthN/A
EPS GrowthN/A
CountryCA
Employees100
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding173,265,300
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-1.34
Price to Sales (P/S)1.29
P/FCF Ratio-5.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Newtopia Business Overview & Revenue Model
Company Description
Newtopia Inc., a health technology company, delivers disease prevention solutions. It offers a personalized habit change platform that focuses on physical and mental health risk reduction. The company was incorporated in 2008 and is headquartered ...
How the Company Makes Money
Newtopia makes money primarily through subscription-based revenue models, where clients, including individuals and employers, pay for access to its personalized health improvement programs. The company partners with employers and health insurers w...
Newtopia Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Newtopia Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | C$10.73M | -1.98 | 64.52% | ― | 7.63% | -106.03% | |
45 Neutral | C$2.89M | -16.67 | -49.83% | ― | -100.00% | 42.39% | |
45 Neutral | C$5.92M | -2.90 | 739.84% | ― | ― | -28.35% | |
44 Neutral | C$58.73M | -2.16 | -444.52% | ― | 415.06% | -54.80% | |
42 Neutral | C$6.48M | -1.87 | 6239.15% | ― | ― | 68.00% |
* General Sector Average
TSE:NEWU.H
Newtopia
0.01
0.00
0.00%
TSE:NDAT
nDatalyze Corp
0.07
0.06
366.67%
TSE:AIDR
Rocket Doctor AI
0.58
-0.10
-14.71%
TSE:CHS
Comprehensive Healthcare Systems Inc
0.39
-0.16
-28.70%
TSE:UDOC
UniDoc Health Corp
0.08
-0.11
-59.46%
TSE:DMED
DiagnaMed Holdings Corp.
0.05
-0.06
-55.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―